The transfer of drugs and therapeutics into human breast milk: an update on selected topics
HC Sachs, Committee on Drugs, DAC Frattarelli… - …, 2013 - publications.aap.org
Many mothers are inappropriately advised to discontinue breastfeeding or avoid taking
essential medications because of fears of adverse effects on their infants. This cautious …
essential medications because of fears of adverse effects on their infants. This cautious …
Grandchild of the NBAS: The NICU N etwork N eurobehavioral S cale (NNNS) A Review of the Research Using the NNNS
A review of the research on the NICU N etwork N eurobehavioral S cale (NNNS) is
presented. The NNNS has good psychometric properties and reliability. Standardized norms …
presented. The NNNS has good psychometric properties and reliability. Standardized norms …
Parental presence and holding in the neonatal intensive care unit and associations with early neurobehavior
LC Reynolds, MM Duncan, GC Smith, A Mathur… - Journal of …, 2013 - nature.com
Objective: To investigate the effects of parental presence and infant holding in the neonatal
intensive care unit (NICU) on neurobehavior at term equivalent. Study Design: Prospective …
intensive care unit (NICU) on neurobehavior at term equivalent. Study Design: Prospective …
Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway …
GK Welle-Strand, S Skurtveit, HE Jones, H Waal… - Drug and alcohol …, 2013 - Elsevier
BACKGROUND: In Norway, most opioid-dependent women are in opioid maintenance
treatment (OMT) with either methadone or buprenorphine throughout pregnancy. The …
treatment (OMT) with either methadone or buprenorphine throughout pregnancy. The …
Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy
AB O'Connor, A Collett, WA Alto… - Journal of midwifery & …, 2013 - Wiley Online Library
Introduction Although a growing body of evidence suggests that buprenorphine is a safe
alternative to methadone in the treatment of opioid‐dependent pregnant women, little is …
alternative to methadone in the treatment of opioid‐dependent pregnant women, little is …
Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical …
B Surran, P Visintainer, S Chamberlain… - Journal of …, 2013 - nature.com
Objective: To compare the efficacy of clonidine versus phenobarbital in reducing morphine
sulfate treatment days for neonatal abstinence syndrome (NAS). Study Design: Prospective …
sulfate treatment days for neonatal abstinence syndrome (NAS). Study Design: Prospective …
Buprenorphine use in pregnant opioid users: a critical review
M Soyka - CNS drugs, 2013 - Springer
Pregnancy in opioid users poses a number of problems to treating physicians. Most
guidelines recommend maintenance treatment to manage opioid addiction in pregnancy …
guidelines recommend maintenance treatment to manage opioid addiction in pregnancy …
Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention
Background Induction onto buprenorphine during pregnancy may be more challenging than
induction onto methadone. This study explores factors predicting withdrawal intensities and …
induction onto methadone. This study explores factors predicting withdrawal intensities and …
[HTML][HTML] Improving maintenance treatment of opiate addiction: Clinical aspects
K Simojoki - 2013 - helda.helsinki.fi
Finland was the first country in Europe to use buprenorphine-naloxone combination
medication as part of 0pioid maintenance treatment (OMT), which was expected to have …
medication as part of 0pioid maintenance treatment (OMT), which was expected to have …
Pregnant women in opioid maintenance treatment (OMT): maternal and neonatal outcomes
IO Lund - 2013 - duo.uio.no
There are approximately 1.4 million individuals with problem opioid use in Europe [1]. In
Norway, the number of problematic opioid users is estimated to about 6900–12300.[2] …
Norway, the number of problematic opioid users is estimated to about 6900–12300.[2] …